4 most recent filings and news items mentioning PROF. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/PROF/news?limit=20"
Pull PROF filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayProfound Medical reported Q2 2026 financial results where operating expenses declined 16% and net loss improved 39%, alongside a correction noting $2.5M in Q3 revenue due to changed shipment timing. The company reiterated full-year 2026 revenue guidance of $25 million noted an ex
View filing at SEC.gov →Profound Medical announced data from its CAPTAIN trial where the TULSA Procedure demonstrated statistically significant superior penile length preservation compared to robotic radical prostatectomy, showing no median change versus a 0.65 cm loss.
View filing at SEC.gov →Profound Medical announced that it will release second quarter 2026 financial results and host a conference call on August 6, 2026. This announcement allows investors to prepare for upcoming insights into the commercial-stage medical device company's performance.
View filing at SEC.gov →Profusa, Inc. amended its charter to authorize a reverse stock split with a ratio between five and two hundred to one. The exact ratio and timing are subject to board determination and may be implemented to maintain Nasdaq listing compliance.
View filing at SEC.gov →